COGT vs KR · $5.75B cap vs P/E 19, rev $147.64B
Cogent Biosciences Inc (COGT) versus Kroger Company (KR) — a side-by-side from cached financials, not a winner call.
Cogent Biosciences Inc (COGT) is a biotechnology company listed on NASDAQ.
Kroger Company (KR) is a grocery stores company listed on US.
COGT does not have a complete income-statement cache yet.
Latest reported KR revenue for 2026-01-31 was $147.64B. Net income was $1.02B. Revenue was up 0.4% from 2025-02-01 to 2026-01-31. KR currently screens at market cap $46.17B and trailing P/E 19.0.
COGT currently screens at market cap $5.75B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Not investment advice. Open the COGT and KR stock pages for the full models.
Not investment advice.